These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8845563)

  • 1. Verapamil-induced hyperprolactinemia complicated by a pituitary incidentaloma.
    Dombrowski RC; Romeo JH; Aron DC
    Ann Pharmacother; 1995 Oct; 29(10):999-1001. PubMed ID: 8845563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Verapamil-induced hyperprolactinemia--a case report].
    Krysiak R; Okopieh B; Herman ZS
    Pol Arch Med Wewn; 2005 Feb; 113(2):155-8. PubMed ID: 16209236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium and prolactin secretion in humans: effects of the channel blocker, verapamil, in the spontaneous and drug-induced hyperprolactinemia.
    Knoepfelmacher M; Villares SM; Nicolau W; Germek OO; Lerário AC; Wajchenberg BL; Liberman B
    Horm Metab Res; 1994 Oct; 26(10):481-5. PubMed ID: 7851873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil stimulation test in hyperprolactinemia: loss of prolactin response in anatomic or functional stalk effect.
    Dagdelen S; Usman A
    Minerva Endocrinol; 2010 Jun; 35(2):53-9. PubMed ID: 20595935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bromocriptine monotherapy of a prolactinoma causing erectile dysfunction].
    López Cubillana P; Hita Rosino E; Asensio Egea L; Rigabert Montiel M; Hita Villaplana G; Server Pastor G; Server Falgás G
    Arch Esp Urol; 1997 Jun; 50(5):526-8. PubMed ID: 9382597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hyperprolactinemia associated with internal carotid artery aneurysm: differential diagnosis between prolactinoma and hypothalamic-pituitary disconnection.
    Duarte FH; Machado MC; Lima JR; Salgado LR
    Arq Bras Endocrinol Metabol; 2008 Oct; 52(7):1189-93. PubMed ID: 19082309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic evaluation of hyperprolactinemia.
    Biller BM
    J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of psychosis associated with a prolactinoma: case report and review of the literature.
    Ali S; Miller KK; Freudenreich O
    Psychosomatics; 2010; 51(5):370-6. PubMed ID: 20833935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia.
    Colao A; Di Sarno A; Cappabianca P; Di Somma C; Pivonello R; Lombardi G
    N Engl J Med; 2003 Nov; 349(21):2023-33. PubMed ID: 14627787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperprolactinemia unrelated to prolactinoma].
    Krysiak R; Okopień B
    Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of 'hook effect'.
    Fleseriu M; Lee M; Pineyro MM; Skugor M; Reddy SK; Siraj ES; Hamrahian AH
    J Neurooncol; 2006 Aug; 79(1):41-3. PubMed ID: 16598425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinaemia due to hypothalamic-pituitary disease or drug-induced in patients with erectile dysfunction.
    Venetikou MS; Lambou T; Gizani D
    Andrologia; 2008 Aug; 40(4):240-4. PubMed ID: 18727734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pituitary prolactinoma with severe erectile dysfunction as the initial symptom: diagnosis and treatment of 4 cases].
    Jiang T; Zheng L; Su XM; Peng JQ; Sun DC; Li QL; Zhang ZW; Wang FP; Jiang H
    Zhonghua Nan Ke Xue; 2013 Feb; 19(2):141-3. PubMed ID: 23441455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-induced hyperprolactinemia.
    Molitch ME
    Mayo Clin Proc; 2005 Aug; 80(8):1050-7. PubMed ID: 16092584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudotumor cerebri and prolactin secreting pituitary adenoma. Association or coincidence?
    Jamjoom BA; Sharab MA; Nasser TA; Jamjoom AB
    Neurosciences (Riyadh); 2010 Jul; 15(3):200-3. PubMed ID: 20831031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for macroprolactinaemia and pituitary imaging studies.
    Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacodynamic metoclopramide (cerucal) test in differential diagnosis of hypoprolactinemic hypogonadism syndrome in women].
    Balabolkin MI; Gerasimov GA; Liubimov AV
    Akush Ginekol (Mosk); 1990 Feb; (2):54-7. PubMed ID: 2339765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive Giant Prolactinoma.
    Alkhaibary A; Alharbi A; Khairy S
    World Neurosurg; 2024 Jan; 181():21-22. PubMed ID: 37827431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 22-year-old man with severe osteoporosis due to prolactinoma.
    Dandinoğlu T; Akarsu S; Tekin L; Arbal S; Dinçer U
    J Clin Rheumatol; 2013 Sep; 19(6):341-3. PubMed ID: 23965473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.